IQVIA Holdings Inc
Biotechnology & Medical Research
Company Summary
IQVIA Holdings, Inc. is a pharmaceutical company based in the United States of America with an ESG score of 16.1, indicating low risk. Formed from the merger of Quintiles and IMS Health in 2016, IQVIA specializes in outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. Their technology and analytics segment offers healthcare industry clients aggregated information, technology services, and data capabilities for clinical trials, including virtual trials. Additionally, the company operates a contract sales business.
Website : https://www.iqvia.com/
ESG Rating Overview
Sustainalytics
Overall ESG Rating :
19.2
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
Ranking
Industry Group
Pharmaceuticals37 out of 921
Universe
Global Universe2468 out of 16215
LSEG
Overall ESG Rating :
66
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
MSCI
Overall ESG Rating :
BBB
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader
IQVIA is average among 82 companies in the health care equipment & supplies industry.
Temperature Rise :
1.6℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned
